Home » Peregrine Cancer Drug Shows Promise in Midstage Study
Peregrine Cancer Drug Shows Promise in Midstage Study
Peregrine Pharmaceuticals Inc said its experimental drug for the treatment of lung cancer met the main goal in the first phase of a mid-stage study, sending its shares up 23 percent before the bell.
CNBC
CNBC
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May